Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.
| Descriptor ID |
D056648
|
| MeSH Number(s) |
C14.907.940.897.249 C20.111.193
|
| Concept/Terms |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis
- ANCA-Associated Vasculitis
- ANCA Associated Vasculitis
- Vasculitis, ANCA-Associated
- Pauci-Immune Vasculitis
- Pauci Immune Vasculitis
- Pauci-Immune Vasculitides
- Vasculitides, Pauci-Immune
- Vasculitis, Pauci-Immune
- ANCA-Associated Vasculitides
- ANCA Associated Vasculitides
- ANCA-Associated Vasculitide
- Vasculitide, ANCA-Associated
- Vasculitides, ANCA-Associated
|
Below are MeSH descriptors whose meaning is more general than "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis".
Below are MeSH descriptors whose meaning is more specific than "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis".
This graph shows the total number of publications written about "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" by people in this website by year, and whether "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" by people in Profiles.
-
Daratumumab for the treatment of refractory ANCA-associated vasculitis. RMD Open. 2023 01; 9(1).
-
Extracorporeal Membrane Oxygenation Support for Antineutrophil Cytoplasmic Antibody-associated Vasculitides: An ELSO Registry Analysis. ASAIO J. 2022 04 01; 68(4):553-560.
-
Pulmonary manifestations and outcomes in paediatric ANCA-associated vasculitis: a single-centre experience. Rheumatology (Oxford). 2021 07 01; 60(7):3199-3208.
-
Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review. Curr Cardiol Rev. 2021; 17(2):182-187.
-
Lung biopsy in the diagnosis of pediatric ANCA-associated vasculitis. Pediatr Pulmonol. 2021 01; 56(1):145-152.
-
Checkpoint inhibitor-related renal vasculitis and use of rituximab. J Immunother Cancer. 2020 07; 8(2).
-
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):281-295.
-
Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol. 2017 05; 69(5):1054-1066.
-
ANCA-mediated crescentic glomerulonephritis with linear deposition of IgG along the glomerular basement membrane. Saudi J Kidney Dis Transpl. 2014 May; 25(3):634-7.
-
Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination. Am J Nephrol. 2013; 38(2):174-8.